Table 1.
Individual | Geometric mean IC50 titera | Number of viruses neutralizedb | Date of SCc | Months from SC to CVId | CD4 count at SPe | Viral load (log) at SPf | Env sequences obtainedg | Neutralization assay performedh | SH analysis performedi |
---|---|---|---|---|---|---|---|---|---|
ACH19829 |
297 |
6 |
26-jan-86 |
10.5 |
440 |
3.9 |
gp160 |
+ |
+ |
ACH18969 |
275 |
5 |
29-Oct-87 |
1.8 |
520 |
4.3 |
gp160 |
+ |
+ |
ACH19308 |
231 |
5 |
14-jul-91 |
3.3 |
380 |
4.4 |
gp160 |
+ |
+ |
ACH18814 |
230 |
6 |
27-jul-87 |
3.2 |
500 |
5.1 |
gp160 |
+ |
+ |
ACH18818 |
205 |
4 |
26-jan-86 |
8.2 |
510 |
5.4 |
gp160 |
+ |
+ |
ACH19885 |
180 |
5 |
28-dec-94 |
2.9 |
580 |
3.3 |
gp160 |
+ |
+ |
ACH11668 |
169 |
5 |
28-jun-86 |
7.9 |
380 |
4.5 |
gp160 |
+ |
+ |
ACH19463 |
164 |
5 |
14-jul-86 |
2.1 |
350 |
4.8 |
gp160 |
+ |
+ |
ACH19507 |
140 |
6 |
23-apr-88 |
7.9 |
400 |
5.0 |
gp160 |
+ |
+ |
ACH19474 |
126 |
5 |
27-jul-87 |
12.7 |
410 |
3.0 |
gp160 |
+ |
+ |
ACH19999 |
111 |
4 |
26-aug-85 |
4.3 |
1060 |
4.6 |
gp160 |
+ |
+ |
ACH19793 |
93 |
4 |
28-jun-86 |
12.3 |
1000 |
4.5 |
gp160 |
+ |
+ |
ACH19588 |
91 |
4 |
20-nov-85 |
13.8 |
600 |
5.3 |
gp160 |
- |
- |
ACH19566 |
78 |
5 |
11-Mar-85 |
13.2 |
610 |
3.5 |
C1-V5 |
- |
- |
ACH19768 |
64 |
5 |
6-apr-86 |
2.2 |
370 |
3.7 |
gp160 |
- |
- |
ACH18860 |
64 |
2 |
25-aug-86 |
2.6 |
550 |
4.9 |
C1-V5 |
- |
- |
ACH18839 |
64 |
3 |
17-Oct-86 |
3.3 |
330 |
3.8 |
C1-V5 |
- |
- |
ACH19542 |
45 |
3 |
23-jun-85 |
4.5 |
310 |
3.9 |
gp160 |
- |
- |
ACH18766 |
43 |
1 |
15-jul-88 |
5.1 |
760 |
4.3 |
gp160 |
- |
- |
ACH19861 |
43 |
3 |
24-feb-89 |
3.0 |
470 |
4.3 |
gp160 |
+ |
+ |
ACH19453 |
39 |
3 |
23-dec-85 |
7.0 |
810 |
3.0 |
gp160 |
- |
- |
ACH18829 |
38 |
3 |
2-feb-87 |
4.0 |
770 |
2.6 |
C1-V5 |
- |
- |
ACH19792 |
34 |
2 |
8-nov-85 |
6.9 |
450 |
4.9 |
gp160 |
+ |
+ |
ACH19961 |
31 |
0 |
14-sep-87 |
2.4 |
530 |
4.5 |
gp160 |
+ |
+ |
ACH19329 |
31 |
1 |
28-dec-94 |
4.3 |
780 |
3.9 |
gp160 |
+ |
+ |
ACH19974 |
29 |
2 |
26-jan-86 |
8.8 |
550 |
3.5 |
gp160 |
+ |
+ |
ACH19489 |
29 |
0 |
30-sep-85 |
7.4 |
550 |
3.1 |
gp160 |
+ |
+ |
ACH18887 |
29 |
1 |
7-dec-89 |
8.8 |
670 |
4.6 |
gp160 |
+ |
+ |
ACH19342 |
28 |
2 |
14-jul-86 |
3.0 |
700 |
3.9 |
C1-V5 |
- |
- |
ACH19576 |
23 |
1 |
2-feb-88 |
7.0 |
500 |
4.5 |
gp160 |
+ |
+ |
ACH18880 | 20 | 0 | 28-jun-86 | 10.4 | 860 | 4.8 | gp160 | + | + |
aNeutralization titers are expressed as the geometric mean of the reciprocal plasma dilution that inhibited virus infection by 50% for the panel of 6 heterologous viruses.
bThe number of viruses neutralized, at least 3-fold higher than the IC50 of the same serum with MLV, from the panel of 6 heterologous viruses from different subtypes.
cDate of seroconversion (SC).
dMonths post SC to time of clonal virus isolation (CVI).
eCD4+ T-cell (CD4+) count at setpoint (SP).
fLog viral load at setpoint (SP).
gEnv fragment sequenced.
hIndividuals from which viruses were used in the neutralization sensitivity assay with MAbs and polyclonal HIVIg pools are indicated with +.
IIndividuals from which viral sequences were used in the Sequence Harmony model are indicated with +.